您当前的位置:
首页 >
文章列表页 >
Aspongopus chinensis-derived cytochrome c delivered via lentivirus-like particles induces mitochondrial apoptosis to inhibit HER2-positive breast cancer
Monographic Reports | 更新时间:2026-10-01
    • Aspongopus chinensis-derived cytochrome c delivered via lentivirus-like particles induces mitochondrial apoptosis to inhibit HER2-positive breast cancer

    • Journal of Army Medical University   Vol. 48, Issue 18, Pages: 2578-2592(2026)
    • 作者机构:

      1.贵州中医药大学第二临床医学院,贵州贵阳

      2.贵州中医药大学第一附属医院,急诊科,贵州贵阳

      4.贵州中医药大学第一附属医院,党委办公室,贵州贵阳

      7.贵州中医药大学第一附属医院,重症医学科,贵州贵阳

      3.贵州医科大学附属医院重症医学科,贵州贵阳

      5.遵义医科大学附属医院甲乳外科,贵州遵义

      6.黑龙江中医药大学护理学院,黑龙江哈尔滨

      8.贵州中医药大学第二附属医院心血管内科,贵州贵阳

    • DOI:10.16016/j.2097-0927.202604068    

      CLC: R285.5;R730.23;R737.9
    • Received:19 April 2026,

      Revised:2026-06-15,

      Accepted:20 June 2026,

      Published:30 September 2026

    移动端阅览

  • Li X P,Jia B T,Yang X T,et al.Aspongopus chinensis-derived cytochrome c delivered via lentivirus-like particles induces mitochondrial apoptosis to inhibit HER2-positive breast cancer[J].J Army Med Univ,2026,48(18):2578-2592.DOI:10.16016/j.2097-0927.202604068. DOI:

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

8

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Frontiers and future directions in radiotherapy for breast cancer: considerations of net clinical benefit
Resistance to antibody-drug conjugates in breast cancer: mechanism and strategies for overcoming
Luteolin induces mitochondria-dependent apoptosis and senescence in myelodysplastic syndrome cells by targeting the Akt signaling pathway
Expression of miR-616 in osteosarcoma and its role in proliferation, apoptosis, migration and invasion of tumor cells
Regulation and mechanism of Gm49394 on islet-β cell apoptosis

Related Author

Sun Jianguo
Niu Kai
Qi Xiaowei
Tian Hao
LI Jiarun
YANG Xueqing
YANG Guancui
TIAN Xiaolong

Related Institution

Department of Oncology, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Breast and Thyroid Surgery, Chongqing Key Laboratory of Minimally Invasive and Precision Diagnosis and Treatment of Breast Cancer, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Medical Center of Hematology, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Pathology, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Immunology, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University)
0